BRK-B vs ISBA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
ISBA presents a stable financial profile with a Piotroski F-Score of 4/9, indicating a baseline of stability despite lacking strong momentum in health metrics. The stock is currently trading at $48.70, which is slightly above its Graham Number ($42.66) but significantly below its growth-based Intrinsic Value ($75.52). Strong double-digit revenue and earnings growth, combined with a compressing forward P/E of 12.18, suggest an attractive valuation for a growth-oriented regional bank. However, the bearish technical trend score (0/100) suggests a potential short-term correction despite the long-term price surge.
Compare Another Pair
Related Comparisons
BRK-B vs ISBA: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Isabella Bank Corporation (ISBA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.